06:22 PM, 17th Jul 2023
TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30 2023.2) To consider and approve the closure of subsidiary company M/s. Peroral Bio Private Limited.3) To consider and approve an extension for the date of Annual General Meeting (AGM) of the Company for the financial year 2022-23.4) To consider and approve the appointment of M/s Geeta Serwani & Associates as Secretarial Auditor of the Company for the financial year 2022-23.5) To consider and approve the appointment of Ms. Vasavi & Co as Internal Auditors of the Company for the financial year 2022-23.6) To transact such other business as may be required.